ONTOLOGY REPORT - ANNOTATIONS
| Term: | N-methyl-N'-nitro-N-nitrosoguanidine |
|
| Accession: | CHEBI:21759
|
browse the term
|
| Definition: | An N-nitroguanidine compound having nitroso and methyl substituents at the N'-position |
| Synonyms: | related_synonym: | 1-Methyl-1-nitroso-3-nitroguanidine; 1-Methyl-3-nitro-1-nitrosoguanidine; 1-Nitroso-3-nitro-1-methylguanidine; C2H5N5O3; CN(N=O)C(=N)N[N+]([O-])=O; InChI=1S/C2H5N5O3/c1-6(5-8)2(3)4-7(9)10/h1H3,(H2,3,4); InChIKey=VZUNGTLZRAYYDE-UHFFFAOYSA-N; MNG; MNNG; Methylnitronitrosoguanidine; N'-Nitro-N-nitroso-N-methylguanidine; N-Methyl-N',2-dioxohydrazinecarboximidohydrazide 2-oxide; N-Methyl-N-nitrosonitroguanidin; N-Nitroso-N-methyl-N'-nitroguanidine |
| | alt_id: | CHEBI:34872 |
| | xref_casrn: | 70-25-7 |
| | xref: | Beilstein:1779490 "Beilstein Registry Number"; ChEMBL:153803 "ChEMBL COMPOUND"; ChemIDplus:70-25-7 "CAS Registry Number"; KEGG COMPOUND:70-25-7 "CAS Registry Number"; KEGG COMPOUND:C14592 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D008769 |
| | xref: | NIST Chemistry WebBook:70-25-7 "CAS Registry Number" |
|
|
N-methyl-N'-nitro-N-nitrosoguanidine
|
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Acox2 |
acyl-CoA oxidase 2, branched chain |
|
decreases expression |
EXP |
15 |
18,645,349 |
18,677,855 |
RGD:6480464 |
CTD |
| G |
Adam10 |
ADAM metallopeptidase domain 10 |
|
increases expression |
ISO |
8 |
75,200,657 |
75,289,572 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
multiple interactions |
ISO |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
increases localization |
ISO |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases secretion |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
multiple interactions |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases expression |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
decreases expression |
ISO |
5 |
80,119,742 |
80,129,962 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
ISO |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
affects response to substance |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
multiple interactions |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
decreases expression |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apc |
adenomatous polyposis coli |
|
increases expression |
ISO |
18 |
26,732,147 |
26,790,383 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Araf |
v-raf murine sarcoma 3611 viral oncogene homolog |
|
increases expression |
ISO |
X |
12,556,904 |
12,568,583 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
increases response to substance |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atp1b3 |
ATPase, Na+/K+ transporting, beta 3 polypeptide |
|
decreases expression |
ISO |
8 |
101,405,877 |
101,437,757 |
RGD:6480464 |
CTD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
increases expression |
ISO |
1 |
80,964,751 |
80,994,300 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases expression |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene |
|
increases expression |
ISO |
5 |
58,329,720 |
58,342,293 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcat2 |
branched chain amino acid transaminase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
96,038,287 |
96,055,622 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
multiple interactions |
EXP |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bgn |
biglycan |
|
multiple interactions |
ISO |
X |
159,380,557 |
159,393,409 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
decreases expression |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
increases expression |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
|
multiple interactions |
ISO |
1 |
82,528,943 |
82,546,606 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
decreases expression |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
increases expression |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca2 |
breast cancer 2, early onset |
|
increases expression |
ISO |
12 |
4,282,952 |
4,323,693 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, B chain |
|
increases expression |
EXP |
5 |
155,647,524 |
155,653,074 |
RGD:6480464 |
CTD |
| G |
C1s |
complement component 1, s subcomponent |
|
increases expression |
EXP |
4 |
160,736,133 |
160,748,133 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
multiple interactions |
ISO |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cbx5 |
chromobox homolog 5 |
|
decreases expression |
ISO |
7 |
142,107,922 |
142,125,543 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
increases expression |
ISO |
2 |
144,275,211 |
144,285,196 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccnh |
cyclin H |
|
increases expression |
ISO |
2 |
14,179,894 |
14,200,704 |
RGD:6480464 |
CTD |
| G |
Cct2 |
chaperonin containing TCP1, subunit 2 (beta) |
|
multiple interactions |
ISO |
7 |
56,391,341 |
56,404,084 |
RGD:6480464 |
CTD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
increases mutagenesis |
ISO |
3 |
89,243,600 |
89,245,129 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
multiple interactions |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cdh8 |
cadherin 8 |
|
decreases expression |
ISO |
19 |
5,685,862 |
6,014,208 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk5 |
cyclin-dependent kinase 5 |
|
increases expression |
ISO |
4 |
6,119,704 |
6,124,186 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
decreases expression |
ISO |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Clta |
clathrin, light chain A |
|
multiple interactions |
ISO |
5 |
60,484,437 |
60,502,432 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col6a1 |
collagen, type VI, alpha 1 |
|
multiple interactions |
ISO |
20 |
12,320,102 |
12,338,500 |
RGD:6480464 |
CTD |
| G |
Col8a1 |
collagen, type VIII, alpha 1 |
|
multiple interactions |
ISO |
11 |
43,604,994 |
43,733,870 |
RGD:6480464 |
CTD |
| G |
Cox6a1 |
cytochrome c oxidase, subunit VIa, polypeptide 1 |
|
multiple interactions |
ISO |
12 |
42,530,091 |
42,533,144 |
RGD:6480464 |
CTD |
| G |
Cox8a |
cytochrome c oxidase subunit VIIIa |
|
multiple interactions |
ISO |
1 |
209,886,141 |
209,888,462 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
multiple interactions |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
multiple interactions |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
decreases expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyb561d2 |
cytochrome b561 family, member D2 |
|
decreases expression |
ISO |
8 |
112,787,042 |
112,789,564 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
decreases expression |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
decreases expression |
EXP |
7 |
35,004,234 |
35,045,191 |
RGD:6480464 |
CTD |
| G |
Deaf1 |
DEAF1 transcription factor |
|
decreases expression |
ISO |
1 |
201,491,091 |
201,524,767 |
RGD:6480464 |
CTD |
| G |
Dek |
DEK oncogene |
|
increases expression |
ISO |
17 |
23,633,551 |
23,655,507 |
RGD:6480464 |
CTD |
| G |
Dlg1 |
discs, large homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
11 |
70,735,283 |
70,930,374 |
RGD:6480464 |
CTD |
| G |
Dstn |
destrin |
|
increases expression |
ISO |
3 |
132,358,484 |
132,385,198 |
RGD:6480464 |
CTD |
| G |
Dut |
deoxyuridine triphosphatase |
|
affects localization |
ISO |
3 |
112,551,434 |
112,562,434 |
RGD:6480464 |
CTD |
| G |
Dut |
deoxyuridine triphosphatase |
|
increases secretion |
ISO |
3 |
112,551,434 |
112,562,434 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
affects activity |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
affects localization |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Eif1 |
eukaryotic translation initiation factor 1 |
|
multiple interactions |
ISO |
10 |
89,255,637 |
89,257,728 |
RGD:6480464 |
CTD |
| G |
Eif1l1 |
eukaryotic translation initiation factor 1-like 1 |
|
multiple interactions |
ISO |
5 |
21,736,137 |
21,736,478 |
RGD:6480464 |
CTD |
| G |
Eif3e |
eukaryotic translation initiation factor 3, subunit E |
|
increases expression |
ISO |
7 |
79,013,224 |
79,045,970 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
decreases expression |
ISO |
6 |
136,311,381 |
136,318,586 |
RGD:6480464 |
CTD |
| G |
Eif5a |
eukaryotic translation initiation factor 5A |
|
multiple interactions |
ISO |
10 |
56,760,289 |
56,764,689 |
RGD:6480464 |
CTD |
| G |
Elk3 |
ELK3, member of ETS oncogene family |
|
increases expression |
ISO |
7 |
30,278,949 |
30,314,430 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
increases expression |
ISO |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
increases expression |
EXP |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
increases expression |
ISO |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Epha1 |
Eph receptor A1 |
|
increases expression |
ISO |
4 |
70,127,872 |
70,142,309 |
RGD:6480464 |
CTD |
| G |
Ephb3 |
Eph receptor B3 |
|
decreases expression |
ISO |
11 |
82,027,632 |
82,046,332 |
RGD:6480464 |
CTD |
| G |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
|
multiple interactions |
ISO |
4 |
174,601,291 |
174,672,247 |
RGD:6480464 |
CTD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
increases expression |
ISO |
10 |
87,219,157 |
87,242,919 |
RGD:6480464 |
CTD |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
increases expression |
ISO |
9 |
66,843,898 |
67,967,970 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases expression |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases expression |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases expression |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Ets1 |
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
increases expression |
ISO |
8 |
32,481,694 |
32,545,237 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fau |
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed |
|
multiple interactions |
ISO |
1 |
208,695,065 |
208,696,580 |
RGD:6480464 |
CTD |
| G |
Fcer1a |
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
increases expression |
EXP |
13 |
89,429,982 |
89,436,507 |
RGD:6480464 |
CTD |
| G |
Fcgrt |
Fc fragment of IgG, receptor, transporter, alpha |
|
decreases expression |
ISO |
1 |
95,566,717 |
95,575,645 |
RGD:6480464 |
CTD |
| G |
Fes |
feline sarcoma oncogene |
|
increases expression |
ISO |
1 |
136,199,523 |
136,208,759 |
RGD:6480464 |
CTD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
increases expression |
EXP |
2 |
50,866,799 |
50,940,319 |
RGD:6480464 |
CTD |
| G |
Fgfr1op |
Fgfr1 oncogene partner |
|
increases expression |
ISO |
1 |
47,176,365 |
47,205,468 |
RGD:6480464 |
CTD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
multiple interactions |
EXP |
12 |
7,858,092 |
8,035,966 |
RGD:6480464 |
CTD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
increases expression |
EXP |
12 |
7,858,092 |
8,035,966 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
decreases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fst |
follistatin |
|
increases expression |
EXP |
2 |
46,542,246 |
46,550,678 |
RGD:6480464 |
CTD |
| G |
Fstl1 |
follistatin-like 1 |
|
multiple interactions |
ISO |
11 |
64,681,814 |
64,735,673 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
increases expression |
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
decreases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
multiple interactions |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gcgr |
glucagon receptor |
|
decreases expression |
EXP |
10 |
109,921,411 |
109,929,577 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gjb2 |
gap junction protein, beta 2 |
|
increases expression |
EXP |
15 |
36,153,526 |
36,159,490 |
RGD:6480464 |
CTD |
| G |
Gpc4 |
glypican 4 |
|
multiple interactions |
ISO |
X |
138,966,579 |
139,077,074 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
decreases expression |
ISO |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
multiple interactions |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
multiple interactions |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Hba1 |
hemoglobin, alpha 1 |
|
increases expression |
EXP |
10 |
15,584,360 |
15,585,215 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
decreases expression |
ISO |
16 |
36,131,304 |
36,133,878 |
RGD:6480464 |
CTD |
| G |
Hn1 |
hematological and neurological expressed 1 |
|
multiple interactions |
ISO |
10 |
105,579,880 |
105,598,071 |
RGD:6480464 |
CTD |
| G |
Hpgd |
hydroxyprostaglandin dehydrogenase 15 (NAD) |
|
decreases expression |
EXP |
16 |
37,419,901 |
37,457,896 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
multiple interactions |
ISO |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
multiple interactions |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
multiple interactions |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
multiple interactions |
ISO |
9 |
11,033,496 |
11,038,868 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
increases expression |
ISO |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
decreases expression |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
multiple interactions |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
decreases response to substance |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
decreases expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
multiple interactions |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ifitm1 |
interferon induced transmembrane protein 1 |
|
increases expression |
ISO |
1 |
201,154,494 |
201,155,509 |
RGD:6480464 |
CTD |
| G |
Ifitm1 |
interferon induced transmembrane protein 1 |
|
increases expression |
ISO |
1 |
201,154,494 |
201,155,509 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Igsf6 |
immunoglobulin superfamily, member 6 |
|
increases expression |
EXP |
1 |
179,911,684 |
179,922,158 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
multiple interactions |
EXP |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
increases expression |
EXP |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
multiple interactions |
ISO |
X |
159,960,184 |
159,969,180 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
decreases expression |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
decreases expression |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Jmjd6 |
jumonji domain containing 6 |
|
multiple interactions |
ISO |
10 |
106,942,942 |
106,948,652 |
RGD:6480464 |
CTD |
| G |
Kctd12 |
potassium channel tetramerisation domain containing 12 |
|
increases expression |
EXP |
15 |
86,986,827 |
86,987,810 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Kitlg |
KIT ligand |
|
decreases expression |
EXP |
7 |
37,714,157 |
37,795,722 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
decreases expression |
EXP |
7 |
73,821,190 |
73,826,866 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
decreases expression |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
multiple interactions |
ISO |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lgals8 |
lectin, galactoside-binding, soluble, 8 |
|
increases expression |
ISO |
17 |
68,589,595 |
68,614,014 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
decreases expression |
ISO |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
multiple interactions |
ISO |
18 |
47,896,674 |
47,970,829 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Map3k12 |
mitogen activated protein kinase kinase kinase 12 |
|
multiple interactions |
ISO |
7 |
141,254,451 |
141,264,979 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases phosphorylation |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk4 |
mitogen-activated protein kinase 4 |
|
increases expression |
ISO |
18 |
70,707,645 |
70,755,517 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases expression |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
multiple interactions |
ISO |
20 |
41,304,058 |
41,310,104 |
RGD:6480464 |
CTD |
| G |
Max |
MYC associated factor X |
|
increases expression |
ISO |
6 |
99,529,905 |
99,553,851 |
RGD:6480464 |
CTD |
| G |
Mcam |
melanoma cell adhesion molecule |
|
increases expression |
ISO |
8 |
47,105,632 |
47,127,936 |
RGD:6480464 |
CTD |
| G |
Mcam |
melanoma cell adhesion molecule |
|
increases expression |
ISO |
8 |
47,105,632 |
47,127,936 |
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance complex component 2 |
|
decreases expression |
ISO |
4 |
122,977,522 |
122,991,934 |
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance complex component 2 |
|
multiple interactions |
ISO |
4 |
122,977,522 |
122,991,934 |
RGD:6480464 |
CTD |
| G |
Mcm4 |
minichromosome maintenance complex component 4 |
|
decreases expression |
ISO |
11 |
87,169,742 |
87,183,443 |
RGD:6480464 |
CTD |
| G |
Mcm6 |
minichromosome maintenance complex component 6 |
|
multiple interactions |
ISO |
13 |
41,045,677 |
41,070,868 |
RGD:6480464 |
CTD |
| G |
Mcpt1 |
mast cell protease 1 |
|
increases expression |
EXP |
15 |
34,270,481 |
34,273,035 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mecom |
MDS1 and EVI1 complex locus |
|
increases expression |
ISO |
2 |
114,814,409 |
114,882,676 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
decreases expression |
ISO |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
multiple interactions |
ISO |
13 |
83,038,049 |
83,058,802 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
decreases expression |
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mpg |
N-methylpurine-DNA glycosylase |
|
increases response to substance |
ISO |
10 |
15,643,334 |
15,649,561 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
increases expression |
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:6480464 |
CTD |
| G |
Mst1 |
Macrophage stimulating 1 (hepatocyte growth factor-like) |
|
increases expression |
EXP |
8 |
113,348,203 |
113,352,773 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mybl1 |
myeloblastosis oncogene-like 1 |
|
increases expression |
ISO |
5 |
9,136,980 |
9,170,799 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myl2 |
myosin, light chain 2, regulatory, cardiac, slow |
|
increases expression |
ISO |
12 |
35,653,745 |
35,664,700 |
RGD:6480464 |
CTD |
| G |
Myl9 |
myosin, light chain 9, regulatory |
|
increases expression |
ISO |
3 |
147,190,252 |
147,193,865 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
decreases expression |
ISO |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Nbl1 |
neuroblastoma 1, DAN family BMP antagonist |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nrp1 |
neuropilin 1 |
|
increases expression |
EXP |
19 |
58,332,004 |
58,487,686 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
multiple interactions |
ISO |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Pa2g4 |
proliferation-associated 2G4 |
|
multiple interactions |
ISO |
7 |
1,846,628 |
1,854,096 |
RGD:6480464 |
CTD |
| G |
Parg |
poly (ADP-ribose) glycohydrolase |
|
multiple interactions |
ISO |
16 |
7,689,492 |
7,798,104 |
RGD:6480464 |
CTD |
| G |
Parg |
poly (ADP-ribose) glycohydrolase |
|
multiple interactions |
ISO |
16 |
7,689,492 |
7,798,104 |
RGD:6480464 |
CTD |
| G |
Parg |
poly (ADP-ribose) glycohydrolase |
|
affects response to substance |
ISO |
16 |
7,689,492 |
7,798,104 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases activity |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
affects cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases response to substance |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pcbp2 |
poly(rC) binding protein 2 |
|
multiple interactions |
ISO |
7 |
141,232,766 |
141,253,910 |
RGD:6480464 |
CTD |
| G |
Pcdh7 |
protocadherin 7 |
|
decreases expression |
ISO |
14 |
56,609,036 |
57,323,892 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
decreases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
decreases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
increases expression |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
multiple interactions |
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
multiple interactions |
ISO |
3 |
108,216,414 |
108,240,138 |
RGD:6480464 |
CTD |
| G |
Pea15 |
phosphoprotein enriched in astrocytes 15 |
|
increases expression |
ISO |
13 |
88,187,674 |
88,197,296 |
RGD:6480464 |
CTD |
| G |
Pgk1 |
phosphoglycerate kinase 1 |
|
increases expression |
ISO |
X |
94,324,219 |
94,340,193 |
RGD:6480464 |
CTD |
| G |
Plxna3 |
plexin A3 |
|
increases expression |
ISO |
X |
160,261,781 |
160,277,570 |
RGD:6480464 |
CTD |
| G |
Podxl |
podocalyxin-like |
|
multiple interactions |
ISO |
4 |
58,611,904 |
58,658,598 |
RGD:6480464 |
CTD |
| G |
Postn |
periostin, osteoblast specific factor |
|
decreases expression |
EXP |
2 |
143,537,099 |
143,568,341 |
RGD:6480464 |
CTD |
| G |
Prkd1 |
protein kinase D1 |
|
increases expression |
ISO |
6 |
70,364,135 |
70,682,006 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
decreases response to substance |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Ptn |
pleiotrophin |
|
multiple interactions |
ISO |
4 |
64,078,755 |
64,160,135 |
RGD:6480464 |
CTD |
| G |
Ptp4a1 |
protein tyrosine phosphatase type IVA, member 1 |
|
increases expression |
ISO |
9 |
29,617,636 |
29,625,197 |
RGD:6480464 |
CTD |
| G |
Ptpra |
protein tyrosine phosphatase, receptor type, A |
|
decreases expression |
ISO |
3 |
118,061,713 |
118,171,300 |
RGD:6480464 |
CTD |
| G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
|
decreases expression |
ISO |
15 |
14,449,352 |
15,130,760 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
multiple interactions |
ISO |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Racgap1 |
Rac GTPase-activating protein 1 |
|
multiple interactions |
ISO |
7 |
138,366,356 |
138,395,716 |
RGD:6480464 |
CTD |
| G |
Rad21 |
RAD21 homolog (S. pombe) |
|
multiple interactions |
ISO |
7 |
88,267,648 |
88,294,703 |
RGD:6480464 |
CTD |
| G |
Rad23a |
RAD23 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
19 |
24,971,070 |
24,976,901 |
RGD:6480464 |
CTD |
| G |
Rad23a |
RAD23 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
19 |
24,971,070 |
24,976,901 |
RGD:6480464 |
CTD |
| G |
Rbbp5 |
retinoblastoma binding protein 5 |
|
increases expression |
ISO |
13 |
45,364,906 |
45,391,757 |
RGD:6480464 |
CTD |
| G |
Rbm6 |
RNA binding motif protein 6 |
|
increases expression |
ISO |
8 |
113,027,975 |
113,128,713 |
RGD:6480464 |
CTD |
| G |
Reck |
reversion-inducing-cysteine-rich protein with kazal motifs |
|
multiple interactions |
EXP |
5 |
60,341,438 |
60,407,710 |
RGD:6480464 |
CTD |
| G |
Reck |
reversion-inducing-cysteine-rich protein with kazal motifs |
|
decreases expression |
EXP |
5 |
60,341,438 |
60,407,710 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
increases expression |
EXP |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Rgs18 |
regulator of G-protein signaling 18 |
|
increases expression |
EXP |
13 |
58,607,898 |
58,629,597 |
RGD:6480464 |
CTD |
| G |
Ros1 |
c-ros oncogene 1 , receptor tyrosine kinase |
|
increases expression |
EXP |
20 |
30,755,101 |
30,910,604 |
RGD:6480464 |
CTD |
| G |
Rpl7 |
ribosomal protein L7 |
|
multiple interactions |
ISO |
5 |
2,315,766 |
2,318,774 |
RGD:6480464 |
CTD |
| G |
Rps11 |
ribosomal protein S11 |
|
multiple interactions |
ISO |
1 |
95,596,744 |
95,598,852 |
RGD:6480464 |
CTD |
| G |
Rps20 |
ribosomal protein S20 |
|
multiple interactions |
ISO |
5 |
17,119,797 |
17,120,959 |
RGD:6480464 |
CTD |
| G |
Rpsa |
ribosomal protein SA |
|
increases expression |
ISO |
8 |
125,100,239 |
125,104,096 |
RGD:6480464 |
CTD |
| G |
Rrm2b |
ribonucleotide reductase M2 B (TP53 inducible) |
|
increases expression |
ISO |
7 |
73,432,161 |
73,459,541 |
RGD:6480464 |
CTD |
| G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
increases expression |
ISO |
20 |
4,671,489 |
4,681,058 |
RGD:6480464 |
CTD |
| G |
Sec61g |
SEC61, gamma subunit |
|
multiple interactions |
ISO |
14 |
97,323,315 |
97,329,689 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
multiple interactions |
ISO |
2 |
52,451,883 |
52,462,263 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serping1 |
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
|
increases expression |
ISO |
3 |
67,968,808 |
67,978,102 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
decreases expression |
ISO |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Snrpn |
small nuclear ribonucleoprotein polypeptide N |
|
increases expression |
ISO |
1 |
111,570,605 |
111,592,659 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
decreases expression |
ISO |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
increases expression |
ISO |
18 |
37,090,934 |
37,099,835 |
RGD:6480464 |
CTD |
| G |
Spint2 |
serine peptidase inhibitor, Kunitz type, 2 |
|
decreases expression |
ISO |
1 |
84,393,845 |
84,416,299 |
RGD:6480464 |
CTD |
| G |
Spint2 |
serine peptidase inhibitor, Kunitz type, 2 |
|
increases expression |
ISO |
1 |
84,393,845 |
84,416,299 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
increases expression |
ISO |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
multiple interactions |
ISO |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Srsf7 |
serine/arginine-rich splicing factor 7 |
|
decreases expression |
ISO |
6 |
3,101,772 |
3,104,433 |
RGD:6480464 |
CTD |
| G |
Stk39 |
serine threonine kinase 39 |
|
decreases expression |
ISO |
3 |
50,249,626 |
50,517,085 |
RGD:6480464 |
CTD |
| G |
Syn1 |
synapsin I |
|
multiple interactions |
ISO |
X |
12,512,241 |
12,556,160 |
RGD:6480464 |
CTD |
| G |
Tbrg4 |
transforming growth factor beta regulator 4 |
|
increases expression |
ISO |
14 |
87,372,275 |
87,378,266 |
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Thbs2 |
thrombospondin 2 |
|
multiple interactions |
ISO |
1 |
53,584,406 |
53,613,652 |
RGD:6480464 |
CTD |
| G |
Tiam1 |
T-cell lymphoma invasion and metastasis 1 |
|
increases expression |
ISO |
11 |
30,123,752 |
30,252,936 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
decreases expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
increases expression |
EXP |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tmsb4x |
thymosin beta 4, X-linked |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnc |
tenascin C |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
|
increases expression |
ISO |
5 |
169,344,695 |
169,348,961 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
multiple interactions |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases acetylation |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tram1 |
translocation associated membrane protein 1 |
|
increases expression |
ISO |
5 |
4,844,208 |
4,869,207 |
RGD:6480464 |
CTD |
| G |
Ttc3 |
tetratricopeptide repeat domain 3 |
|
multiple interactions |
ISO |
11 |
34,617,072 |
34,659,043 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
multiple interactions |
ISO |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Ubc |
ubiquitin C |
|
multiple interactions |
ISO |
12 |
32,333,211 |
32,337,944 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
increases expression |
ISO |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
multiple interactions |
ISO |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
increases expression |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
increases expression |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Wars |
tryptophanyl-tRNA synthetase |
|
decreases expression |
ISO |
6 |
133,200,866 |
133,232,048 |
RGD:6480464 |
CTD |
| G |
Wnt2 |
wingless-type MMTV integration site family member 2 |
|
increases expression |
ISO |
4 |
43,649,783 |
43,689,596 |
RGD:6480464 |
CTD |
Term paths to the root
|